A new study from Massachusetts General Hospital investigators has found, for the first time, evidence of neuroinflammation in key regions of the brains of patients with chronic pain. By showing that levels of an inflammation-linked protein are elevated in regions known to be involved in pain transmission, the study paves the way for the exploration of potential new treatment strategies and possibly for biomarkers reflecting pain conditions.